1 / 37

Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for N

The Medical and Surgical Treatment of Epilepsy. Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square, London WC1N 3BG. The Treatment of Epilepsy. The incidence and prevalence

saddam
Download Presentation

Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for N

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The Medical and Surgical Treatment of Epilepsy Professor Ley Sander Department of Clinical and Experimental Epilepsy UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square, London WC1N 3BG

  2. The Treatment of Epilepsy • The incidence and prevalence • Aetiologies and risk factors • Aims of treatment • Clinical settings • Principles of treatment • Medical treatment • Surgical treatment • Guidelines • Conclusions

  3. Incidence and Prevalence • Incidence of new cases of epilepsy: • 50/100,000/year • Incidence of single seizures: • 20 - 30/100,000/year • Prevalence of active epilepsy • 5 - 10/1,000(50% because on AEDs) • Severe epilepsy: 1 - 2/1,000 • Cumulative Incidence(lifetime prevalence): • 2 - 5%

  4. Incidence and Prevalence in the UK • 30 000 new cases a year • 300 000 - 400 000 cases • 72 000 - 80 000 cases of severe epilepsy

  5. Incidence and Prevalence in the UK • GP • 1 - 2 new cases of epilepsy/year • 10 - 12 cases of active epilepsy • Neurologist • 150 cases of epilepsy/single seizures/year • 1,200 cases of active epilepsy

  6. Epilepsy: Aetiologies and Risk Factors • Risk factors varies with age and geographic location • Congenital, developmental and genetic conditions in childhood, adolescence and young adults • Head trauma, infection and tumours at any age although tumours more likely over age 40 • Cerebrovascular disease common in elderly • Endemic infections are associated with epilepsy in certain areas • malaria, neurocysticercosis, paragonomiasis, • no adequate large scale study of attributable risk yet

  7. Antiepileptic Treatment • AEDs are mainstay treatment • Non-pharmacological options feasible in only few selected cases • Surgery • Curative • Palliative • Ketogenic diet (children) • Behaviour modification • Avoidance therapy in cases with clear precipitants

  8. Aims of Antiepileptic Treatment • Complete seizure freedom • 50% seizure reduction of little benefit • No adverse effects • long term treatment - long term effects ? • cognitive effects debilitating • teratogenicity • Non-obtrusive treatment • once or twice daily • No PK or PD interactions • Maintenance of a normal lifestyle • Reduction in morbidity and mortality

  9. AED Treatment: Clinical Settings • Prophylactic Treatment • Newly Diagnosed Epilepsy • Single seizure • Recurrent seizures • Chronic Epilepsy

  10. Prophylactic use of AEDs • Often advocated after • Head injury • Craniotomy • There are considerable compliance problems • There is no evidence of a protective effect of this policy • No place for this! • Better wait for the event to happen

  11. Is it Epilepsy ? • Newly diagnosed or suspected cases at Primary Care level • > 50% not epilepsy • commonest differential diagnosis: syncope • Chronic cases • 15 - 20% not epilepsy • mostly psychological in nature • Careful diagnostic assessment a must in all cases

  12. The Single Seizure • A controversial area! • Single unprovoked attack usually not treated: practice to defer treatment until 2 or more seizures, although patients at high risk may be treated after a first attack • Incidence of epilepsy much greater than of single seizures • Community-based studies show that overall risk of a second seizure greater than previously accepted • selection bias • Patients • Seizure type • time to entry bias

  13. The Single Seizure • AED treatment following a single seizure reduce risk of recurrence in the short term although long term prognosis not changed • This may eventually lead to changes in the way single seizures are managed • treatment after first seizure • - for six months, for a year? • tailored treatment and not symptomatic • Meanwhile, involve patient and or guardians in the decision

  14. Recurrent Seizures • Treatment recommended after two or more seizures • Exceptions: - Long interval between seizures - Clear identifiable precipitant factor - Patient against treatment - Unlikely compliance

  15. Precipitating Factors • Fever • Drugs • Alcohol • Photo-Sensitivity • Sleep Deprivation • Reflex Mechanisms • Acute Metabolic Stress • Emotional Stress/Major Life Events

  16. Starting an AED • Starting AED treatment is a major event and should not be undertaken without careful evaluation of all relevant factors • Therapy is a long term prospect • All implications must be fully explained to the individual and or guardian • Paramount that the patient or guardians are kept informed about the treatment process and the rationale behind it

  17. Starting Treatment • Treatment should always be started with a single drug at a small dose • All common side-effects must be discussed • teratogenicity and contraception if applicable • Importance of compliance should be stressed • Careful titration is a must - start low, go slow

  18. Choice of AEDs treatment • Choice of AED influenced by: • Type of seizure and or epileptic syndrome • Individual circumstances of patient • Side effect profile of drug • Personal preferences • No clear cut evidence based medicine is available! • Clinical practice is based more on dogmatic teaching than on scientific knowledge • Empirical rather than rational

  19. Principles of AED treatment • Diagnosis clearly established • Appropriate first line drug for syndrome and patient • One drug at a time as a rule: • If first drug ineffective add another first line drug and then withdraw first drug • Combination therapy only when single drug ineffective

  20. What Is Chronic Epilepsy ? • Active 2 years after onset • Failed 2 first line AEDs • Great number of seizure in early history

  21. Chronic Epilepsy 1 • Review history of epilepsy - Obtain and review old notes if possible - Interview patient and witness - Classify seizures • Review diagnosis - Non-epileptic events - Identifiable aetiology - High resolution MRI scanning • Question Compliance • Check serum AED levels • Review past and present AED treatment for efficacy and side-effects

  22. Chronic Epilepsy 2 • Select the AED that is most likely to be efficacious and with the least side-effects • Adjust the dose of the selected drug to the optimum • Attempt to reduce and taper other AEDs • If seizures continue despite a maximally tolerated dose of a first-line drug: - Check compliance • tablet count, serum levels, counselling • Commence another first-line AED if there is one that has not been used to its optimum

  23. Chronic Epilepsy 3 • If seizures continue try a combination of two AEDs • If combination unhelpful, AED which appears most effective and with fewer side-effects should be continued and the other AED replaced • If this drug is effective, withdrawal of the initial agent should be considered; if not, it should be replaced by another AED • Consider the possibility of surgical treatment • Consider using an experimental AED

  24. Inappropriate use of AEDs • Inappropriate treatment of people who do not have epilepsy • Inappropriate drug treatment of patients who do have epilepsy • JME easily treated with some AEDs but poorly controlled with others • Partial epilepsies often misdiagnosed as generalised epilepsy • Incorrect dosages or inappropriate use of polytherapy • Overzealous adherance to “therapeutic” AED drug levels

  25. AED drug levels monitoring • Measurement of AED levels: • drug toxicity occurs and needs to be documented • suspected non-compliance • suspected drug interactions • during pregnancy (free levels) • during systemic illness • phenytoin therapy • Not a guide to dosing!

  26. Who Should be Evaluated for Surgery • Partial seizures: simple, complex, sec gen. • Stereotyped onset • No non-epileptic attacks • No contraindication for Neurosurgery • Active epilepsy for >2-3 yr, despite 3 + AEDs • Inadequate seizure control: > 1-2 c p s /month • Acceptance of best risk / benefit ratio

  27. Best risk vs benefit ratio of temporal lobe epilepsy surgery • MedicalSurgical • Chance of seizure control • 10% 70% • Risk • Morbidity from seizures 1/100 long-lasting impairment • Psychosocial handicap hemiparesis, aphasia • 1/100 Annual mortality 1/20 quandrantanopia prevents driving

  28. Range of Epilepsy Surgery • 70% Anterior temporal lobe resection • 20% Extra-temporal cortical resection • Lesionectomy • 10% Palliative Procedures • Hemispherectomy • Corpus callosotomy • Subpial transection • Vagal Nerve Stimulation

  29. Components of Presurgical Evaluation • Convergence of data • One epileptogenic & dysfunctional area • Rest of brain normal • Clinical • Neuro-Imaging • EEG • Neuropsychology • Neuropsychiatry • Psychosocial

  30. Psychosocial • Realistic expectations? • Improvement in life from seizure control? • Intelligence, memory will not improve • Not more attractive, employable • Need to continue AEDs after • Social support • Family, friends, community, finances

  31. Neuro-imaging • Fundamental • MRI predicts nature and extent of pathology • Unusual to resect area with normal imaging • Poor results if imaging normal

  32. Pathology and Outcome • TLE: Anterior Temporal Lobe resection • Focal pathology: 70% seizure free, 25% >90% reduced • DNT, cavernoma>HS>AVM>trauma>MCD • 20% seizure free if no focal pathology • Extra Temporal Lobe • Focal pathology: 60% seizure free, 20% >90% reduced • DNT, cavernoma, glioma>AVM>trauma • MCD 20-30% seizure free, if focal • <20% seizure free if no focal pathology

  33. Treatment Guidelines for Epilepsy • NICE = www.nice.org.uk – National Institute for Clinical Excellence (England and Wales) • SIGN = www.sign.ac.uk – Scottish Intercollegiate Guidelines Network (Scotland) • AAN = www.aan.com– American Academy of Neurology (USA)

  34. Primary Care Guidelines for Epilepsy • Referral of ALL who experience a suspected seizure • Seen within 14 days by specialist • Risk and safety precautions documented • Care Plan in place • At least a yearly review • Early re-referral if • Treatment failure • Seizures not controlled • Diagnostic uncertainty • Considering pregnancy • Considering drug withdrawal

  35. Managing People With Epilepsy • Holistic issues: • Interest and continuity of care • Clear plan • Information provision • SUDEP • Easy access - Practical Issues: • Cooking, Bathing, Driving, Contraception, Conception - Reasonable Expectations: • Prognosis, Independent Living, Employment

  36. AED Treatment: Conclusions • Correct diagnosis and classification paramount to treatment • AEDs are mainstay treatment • Treatment empirical rather than rational! • > 70% of patients become seizure free • Potential complications: toxicity • Low threshold for s/effects

  37. AED Treatment: Conclusions • Potential for misuse of AEDs not to be dismissed • New AEDs may be better tolerated, but more effective? • Chronic side effect profile of new AEDs not fully known • Surgical treatment very successful but only possible in a few selected cases • Consider stopping AED if seizure free for years • New treatment still needed!

More Related